Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma.
Toledo SP, Lourenço DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE.
Clinics (Sao Paulo). 2009;64(7):699-706. doi: 10.1590/S1807-59322009000700015.
[How to interprete hypercalcitoninemia?].
Levy-Bohbot N, Patey M, Larbre H, Hecart AC, Caron J, Delemer B.
Rev Med Interne. 2006 Aug;27(8):610-5. doi: 10.1016/j.revmed.2006.02.010. Epub 2006 Apr 19.
Hypercalcitoninemia in infancy.
Cannarozzi DB, Canale DD, Donabedian RK.
Clin Chim Acta. 1976 Feb 2;66(3):387-92. doi: 10.1016/0009-8981(76)90238-2.
[Hypercalcitoninemia in conditions other than medullary cancers of the thyroid].
Niccoli P, Conte-Devolx B, Lejeune PJ, Carayon P, Henry JF, Roux F, Wion-Barbot N, Bigorgne JC.
Ann Endocrinol (Paris). 1996;57(1):15-21.
Hypercalcitoninemia, nodular goiter, and pancreatic tumor.
Ghnassia JP, Lindner V, Schneegans O, Haegelé P.
Thyroid. 1999 Jun;9(6):599-600. doi: 10.1089/thy.1999.9.599.
High Prevalence of Hypercalcitoninemia in a Large Cohort of Adult and Pediatric Patients With PTH Resistance Syndromes.
Cremaschi A, Del Sindaco G, Pagnano A, Dolci A, Berkenou J, Rothenbuhler A, Contarino A, Ferrante E, Arosio M, Giannetta E, Linglart A, Mantovani G.
J Clin Endocrinol Metab. 2025 Apr 22;110(5):1334-1341. doi: 10.1210/clinem/dgae416.
Hypercalcitoninemia and thyroid nodules: when cytology (still) matters.
Giovanella L, Giugliano G, Maffini FA, Chiesa F, Bongiovanni M.
Diagn Cytopathol. 2014 Nov;42(11):970-3. doi: 10.1002/dc.23102. Epub 2014 Feb 18.
Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM, Chung KW, Kim SW, Choi SH, Min HS, Kim JN, Won WJ, Kim SK, Lee JI, Chung JH, Kim SW.
Head Neck. 2010 Jan;32(1):68-75. doi: 10.1002/hed.21145.
Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B.
Endocr Relat Cancer. 2009 Mar;16(1):243-53. doi: 10.1677/ERC-08-0059. Epub 2008 Nov 5.
[Non-neoplastic hypercalcitoninemia. Pathological anatomy].
Saint-André JP, Guyétant S.
Ann Endocrinol (Paris). 1996;57(1):23-6.
